

The ZIP study is an international, multisite collaboration to determine the association between Zika during pregnancy and fetal outcomes/associated risks. The study aims to enroll up to 10,000 mother/infant pairs, from whom they will receive biospecimens and data. The PING Consortium has been approved to request these samples, and we will use the resulting analysis to further our goals.
For more info on ZIP, please visit the NIH page and their ClinicalTrials.gov page.
USA
- Children’s National Hospital. Washington, D.C., USA - Roberta DeBiasi, MD
Brazil
- Federal University of Rio Grande do Sul. Porto Alegre, Rio Grande do Sul - Lavinia Schuler- Faccini, MD
- State University of Campinas. Campinas, Sao Paulo - Denise Cavalcanti, MD
- Fluminense Federal University. Niterói, Rio de Janeiro - Priscila Casado, MD
Colombia
- Biomelab S A S. Barranquilla, Colombia - Carlos Cure, MD
Puerto Rico
- University of Puerto Rico School of Medicine. San Juan, Puerto Rico - Maribel Campos, MD
Zika in Infancy and Pregnancy
- Medellin, Colombia
- Pernambuco, Brazil
- Rio de Janeiro, Brazil
- Salvador, Brazil
- Sao Paulo, Brazil
- Nicaragua
- Guatemala
- North Karst, Puerto Rico
- San Juan, Puerto Rico